“A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 Mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence”. 2024. London Journal of Medical and Health Research 24 (6): 63-87. https://journalspress.uk/index.php/LJMHR/article/view/920.